Last updated: March 9, 2026
What is NDC 62011-0270?
NDC 62011-0270 is a specific drug identified under the National Drug Code system. This NDC corresponds to [provide drug name, formulation, and strength], marketed by [manufacturer name]. The drug is primarily used for [approval indication], with competitive landscape including [list primary competitors].
Current Market Landscape
| Parameter |
Data |
| Indications |
[Specify FDA approved indications] |
| Approved Dosages |
[List available dosages] |
| Formulations |
[Liquid, tablet, injectable, etc.] |
| Market Penetration |
Estimated current market share: [percentage] |
| Key Competitors |
[Names of main competing drugs] |
| Market Size (2023) |
Estimated global sales: [$X billion] |
| Growth Rate (2020–2023) |
CAGR: [percentage] |
The drug's FDA approval date was [date], with initial market entry in [year]. The current market is characterized by steady growth driven by [factors like expanding indications, heightened demand, or aging population].
Market Drivers and Barriers
Drivers
- Increasing prevalence of [relevant conditions]
- Expanded approved indications
- Growing reimbursement coverage
Barriers
- Pricing constraints due to healthcare policies
- Competition from biosimilars or generics
- Supply chain disruptions
Price Trends and Projections
| Year |
Price Range (per unit) |
Notes |
| 2023 |
$[X]-$[Y] |
Current average price |
| 2024 |
$[X+Y%]–$[Y+Z%] |
Projected increase based on historical trends |
| 2025 |
$[X+Z%]–$[Y+W%] |
Assumed regulatory and market factors stabilizing |
Historical Price Behavior
In the last three years, unit prices increased by an average of [X]% annually, driven by inflation, manufacturing costs, and demand.
Future Price Projections
Prices are expected to grow at a compounded annual rate (CAGR) of approximately [X]% through 2025, reaching approximately $[projected price] by the end of that year. Price increases will likely be moderated by introduction of generic versions once patents expire, projected around [year].
Patent and Regulatory Context
| Patent Expiration Date |
Market Exclusivity Period |
Impact on Pricing |
| [Date] |
Expected expiry in [year] |
Likely price compression post-expiry |
Patent protection typically sustains premium pricing; expiration tends to result in significant price reductions and increased market competition.
Strategic Factors for Market Expansion
- Collaborations or licensing deals with regional distributors
- Expansion into emerging markets with rising healthcare expenditure
- Development of new formulations or combination therapies
Investment and R&D Implications
Investments in R&D could focus on:
- Novel delivery mechanisms
- New indications
- Biosimilar development post patent expiry
Closing Summary
NDC 62011-0270 operates within a competitive environment influenced by patent protections, regulatory policies, and market demand. The drug's market size is projected to grow at a rate of approximately [X]% annually until 2025, with prices expected to increase accordingly, barring major patent expiries or policy shifts.
Key Takeaways
- The current market size is approximately [$X billion].
- Prices increased at a CAGR of [X]% over the past three years.
- Prices are forecasted to grow at [X]% annually through 2025.
- Patent expiry around [year] will influence pricing and market competition.
- Market expansion opportunities exist in emerging regions and through new formulations.
FAQs
1. When does patent expiration usually occur for drugs like NDC 62011-0270?
Typically after 10-15 years from FDA approval, depending on patent extensions and regulatory filings.
2. How do biosimilars impact pricing for drugs like this?
Biosimilars can reduce prices significantly post-patent expiry, often by 20-40% or more.
3. What factors most influence price increases in this market?
Manufacturing costs, regulatory requirements, demand growth, and competition levels.
4. Are there any upcoming regulatory changes likely to affect this market?
Changes in pricing regulations or reimbursement policies in key markets could alter market dynamics.
5. How does regional regulation affect market entry?
Country-specific approval processes and reimbursement policies can delay or restrict market entry, impacting pricing and market size.
Sources
- U.S. Food & Drug Administration. (2023). Approved Drug Products.
- IQVIA. (2023). Pharmaceutical Market Trends.
- WHO. (2022). World Health Statistics.
- EvaluatePharma. (2023). Market Forecast Series.
- Patent and regulatory filings from the FDA and EMA.
